Overview

REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant

Status:
Not yet recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
This research study will evaluate the effectiveness of postoperative administration of a drug called suvorexant, to improve postoperative sleep and decrease the severity of delirium (serious confusion) in adults 65 years and older undergoing non-cardiac surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Duke University
Collaborator:
Merck Sharp & Dohme LLC
Treatments:
Suvorexant